BSE filing, NSE: BLUEJET. Summary written from the filing by ALFA Finder's alert engine.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹504.55
- Market cap
- ₹8,752 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 37.3×Sector 45.9×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Board Meeting Date
Blue Jet Healthcare scheduled a board meeting on November 5, 2026, to consider Q1 FY27 unaudited results. No financial figures are disclosed.
Blue Jet Healthcare Other Announcement
Blue Jet Healthcare Limited filed its quarterly shareholding pattern for the period ended 30 September 2026 under Regulation 31(1)(b). Promoter and promoter group hold about 73.15% of the equity.
Blue Jet Healthcare Other Announcement
Blue Jet Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Annual Report
Blue Jet Healthcare Limited has released its Annual Report for FY 2025-26. The 58th Annual General Meeting is scheduled for September 21, 2026, via video conferencing.
Blue Jet Healthcare Business Update
Blue Jet Healthcare Limited has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report details the company's ESG performance and statutory disclosures.
Other results update announcements
All →Muthoot Finance Results Update
Muthoot Finance's consolidated profit after tax rose 39% year-on-year to ₹6,103 Crore for the half year. Consolidated loan AUM grew 42% to ₹2,09,317 Crore.
Aditya Birla Lifestyle Brands Results Update
ABLBL reported Q2 FY27 revenue up 11% to Rs.2266 Cr and PAT up 126% to Rs.53 Cr. Network expansion added over 100 stores during the quarter.
Advanced Enzyme Technologies Results Update
Advanced Enzyme Technologies issued a press release highlighting unaudited Q2 and half-year FY27 results. Revenue and profit grew year-on-year, with EBITDA and PAT margins reported.
Eveready Industries India Results Update
Eveready Industries reported Q2 and H1 FY27 unaudited results via press release, with consolidated Q2 revenue of Rs.428.2 crore, up 10.7%. The release also covers the Jammu alkaline facility's commercial production and new product launches.
Central Depository Services (India) Results Update
CDSL's Q2 FY27 media release reports consolidated total income up 22% and net profit up 24% year-on-year. It highlights results for the quarter and half year.
Akme Fintrade (India) Results Update
Akme Fintrade's press release shows H1 FY27 PAT up 19% and AUM crossing Rs. 1,000 crore. The unaudited results were approved by the board.